0.00Open0.00Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover570.75%IV-365.84%PremiumJul 19, 2024Expiry Date1.18Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8077Delta0.7941Gamma0.27Leverage Ratio-0.0034Theta-0.0004Rho-0.22Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet